Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 955
countries: 28
conditions: 2 101

3 955 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Embolism venous

Not recruiting

Registered drugNo placebo

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Abelacimab

Contact Research Centre

Embolism venous+1

Not recruiting

Registered drugNo placebo

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Abelacimab

Contact Research Centre

Philadelphia positive acute lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Blinatumomab

Contact Research Centre

Haemophilia B with anti factor IX+1

Not recruiting

InvestigationalNo placebo

Study on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors

InvestigationalNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Concizumab

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drug

Study on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Sodium Chloride

Contact Research Centre

Biliary tract disorder

Not recruiting

Registered drugNo placebo

Study on Durvalumab and Chemotherapy for Patients with Advanced Biliary Tract Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Essential thrombocythaemia

Not recruiting

Registered drugNo placebo

Study on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bomedemstat

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Acute myeloid leukaemia (in remission)

Not recruiting

Registered drugNo placebo

Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Decitabine

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Imatinib

Contact Research Centre

Prostate cancer recurrent

Not recruiting

Registered drug

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug

Italy

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Find therapies in clinical trials near you – page 3

35 trials match your criteria

Embolism venous

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Embolism venous+1

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Philadelphia positive acute lymphocytic leukaemia

Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Haemophilia B with anti factor IX+1

Study on How Concizumab Works for Patients with Hemophilia A or B with Inhibitors

Chronic lymphocytic leukaemia

Study on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency

Biliary tract disorder

Study on Durvalumab and Chemotherapy for Patients with Advanced Biliary Tract Cancer

Essential thrombocythaemia

Study on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Acute myeloid leukaemia (in remission)

Study on the Effectiveness of Decitabine and Venetoclax for Patients with Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Chronic myeloid leukaemia

Comparison of Nilotinib versus Imatinib treatment in newly diagnosed chronic myeloid leukemia patients to achieve treatment-free remission

Prostate cancer recurrent

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.